29.46
-0.47
(-1.57%)
At close: January 10 at 4:00:00 PM EST
29.89
+0.43
+(1.46%)
After hours: January 10 at 6:19:05 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 9 | 6 | 10 | 10 |
| Avg. Estimate | -0.78 | -0.76 | -2.86 | -3.12 |
| Low Estimate | -0.9 | -0.95 | -3.06 | -4.54 |
| High Estimate | -0.57 | -0.62 | -2.58 | -2.48 |
| Year Ago EPS | -0.79 | -0.79 | -2.91 | -2.86 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 7 | 4 | 8 | 8 |
| Avg. Estimate | 1.74M | 1.98M | 9.74M | 8M |
| Low Estimate | -- | -- | 7.9M | -- |
| High Estimate | 4.9M | 4.9M | 12.8M | 19.7M |
| Year Ago Sales | 2.19M | 3.54M | 9.56M | 9.74M |
| Sales Growth (year/est) | -20.53% | -44.26% | 1.86% | -17.84% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.63 | -0.88 | -0.78 | -0.72 |
| EPS Actual | -0.79 | -0.79 | -0.65 | -0.65 |
| Difference | -0.16 | 0.09 | 0.13 | 0.07 |
| Surprise % | -25.00% | 9.79% | 17.12% | 9.52% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.78 | -0.76 | -2.86 | -3.12 |
| 7 Days Ago | -0.78 | -0.76 | -2.86 | -3.12 |
| 30 Days Ago | -0.75 | -0.75 | -2.8 | -3.07 |
| 60 Days Ago | -0.72 | -0.74 | -2.68 | -2.97 |
| 90 Days Ago | -0.77 | -0.73 | -2.9 | -3.1 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 5 | -- | 6 | -- |
| Down Last 7 Days | 1 | 1 | 2 | 1 |
| Down Last 30 Days | 4 | 1 | 4 | 3 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RNA | 1.15% | 3.59% | 1.81% | -9.18% |
| S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/10/2025 |
| Initiated | HC Wainwright & Co.: Buy | 12/20/2024 |
| Initiated | RBC Capital: Outperform | 11/26/2024 |
| Maintains | Chardan Capital: Buy to Buy | 11/13/2024 |
| Reiterates | Needham: Buy to Buy | 11/13/2024 |
| Reiterates | Needham: Buy to Buy | 10/31/2024 |
Related Tickers
DYN Dyne Therapeutics, Inc.
15.87
-31.15%
STOK Stoke Therapeutics, Inc.
9.00
+0.45%
JANX Janux Therapeutics, Inc.
46.76
-7.99%
VRDN Viridian Therapeutics, Inc.
18.20
-4.96%
DNLI Denali Therapeutics Inc.
19.10
-10.12%
SRRK Scholar Rock Holding Corporation
40.49
-0.88%
CRNX Crinetics Pharmaceuticals, Inc.
40.59
-16.31%
SWTX SpringWorks Therapeutics, Inc.
43.00
+6.20%
VRNA Verona Pharma plc
45.20
-2.16%
RLAY Relay Therapeutics, Inc.
4.4500
-7.87%